SCHEMBL1614869

SCHEMBL1614869

Cc1nn2c(=O)cc(COC(=O)C(F)(F)F)[nH]c2c1-c1ccccc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.38
GPR119 Q8TDV5 1/20 0.38
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 2/20 0.37
NPSR1 Q6W5P4 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
TSHR P16473 1/20 0.37
PLAT P00750 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
HSD17B10 Q99714 2/20 0.35
GLA P06280 1/20 0.35
LMNA P02545 1/20 0.34
MAPK1 P28482 1/20 0.34
CYP1A2 P05177 1/20 0.34
POLB P06746 1/20 0.34
THRB P10828 1/20 0.34
CYP2C9 P11712 1/20 0.34
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15909132 0.88 ARF6 (0.36) MAPTKDM4ENPSR1PLATLMNA
SCHEMBL15908924 0.88 ARF6 (0.42) ALDH1A1KDM4ENPSR1L3MBTL1PLAT
SCHEMBL15909266 0.84 ARF6 (0.39) MAPTKDM4ENPSR1TDP1PLAT
SCHEMBL1614818 0.83 GPR119 (0.41) MAPTGPR119ALDH1A1KDM4ENPSR1
SCHEMBL1614054 0.78 MEN1 (0.41) MAPTALDH1A1KDM4EL3MBTL1PLAT
SCHEMBL15926347 0.77 ARF6 (0.41) ALDH1A1KDM4ENPSR1L3MBTL1PLAT
SCHEMBL1614895 0.77 PLAT (0.38) ALDH1A1PLAT
SCHEMBL1614756 0.76 KDM4E (0.50) MAPTALDH1A1KDM4ENPSR1PLAT
SCHEMBL15909113 0.75 POLB (0.36) MAPTALDH1A1KDM4ELMNAPOLB
SCHEMBL1613466 0.73 AR (0.40) MAPTGPR119PLAT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796285-B2 Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof HEBEI MEDICAL UNIVERSITY (CN) 2014-08-05 US disclosed
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof PEKING UNIVERSITY (CN) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof KCNJ2, KCNQ5, KCNJ11 MAPT 1089/4885GPR119 2319/4885ALDH1A1 159/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.